The controlled release of neurotrophic proteins from the conducting polymer polypyrrole to improve the nerve/cochlear implant interface by Thompson, Brianna C
University of Wollongong 
Research Online 
University of Wollongong Thesis Collection 
1954-2016 University of Wollongong Thesis Collections 
2009 
The controlled release of neurotrophic proteins from the conducting 
polymer polypyrrole to improve the nerve/cochlear implant interface 
Brianna C. Thompson 
University of Wollongong, brianna@uow.edu.au 
Follow this and additional works at: https://ro.uow.edu.au/theses 
University of Wollongong 
Copyright Warning 
You may print or download ONE copy of this document for the purpose of your own research or study. The University 
does not authorise you to copy, communicate or otherwise make available electronically to any other person any 
copyright material contained on this site. 
You are reminded of the following: This work is copyright. Apart from any use permitted under the Copyright Act 
1968, no part of this work may be reproduced by any process, nor may any other exclusive right be exercised, 
without the permission of the author. Copyright owners are entitled to take legal action against persons who infringe 
their copyright. A reproduction of material that is protected by copyright may be a copyright infringement. A court 
may impose penalties and award damages in relation to offences and infringements relating to copyright material. 
Higher penalties may apply, and higher damages may be awarded, for offences and infringements involving the 
conversion of material into digital or electronic form. 
Unless otherwise indicated, the views expressed in this thesis are those of the author and do not necessarily 
represent the views of the University of Wollongong. 
Recommended Citation 
Thompson, Brianna C., The controlled release of neurotrophic proteins from the conducting polymer 
polypyrrole to improve the nerve/cochlear implant interface, Doctor of Philosophy thesis, School of 
Chemistry, University of Wollongong, 2009. https://ro.uow.edu.au/theses/3067 
Research Online is the open access institutional repository for the University of Wollongong. For further information 






THE  CONTROLLED  RELEASE OF NEUROTROPHIC PROTEINS 
FROM THE CONDUCTING POLYMER POLYPYRROLE TO 
IMPROVE THE NERVE/COCHLEAR IMPLANT INTERFACE  
 
 
A thesis submitted in fulfilment of the 
requirements for the award of the degree 
 
 
DOCTOR OF PHILOS OPHY  
from 
UNIVER SITY OF WOLLONGONG  
by 








I, Brianna C. Thompson, declare that this thesis, submitted in fulfilment of the 
requirements for the award of Doctor of Phil sophy, in the School of Chemistry, 
University of Wollongong, is wholly my own work unless otherwise referenced or 





Brianna C. Thompson 
th
20  January, 2009 
- ii - 
ABSTRACT  
 
The cochlear implant has restored hearing to hundreds of thousands of profoundly deaf 
individuals since the early 1980s. The implant works by providing electrical stimulation 
directly to the auditory nerves, bypassing the damaged sensory processes. As the 
electrodes of the cochlear implant are required to directly stimulate the auditory nerves, 
the interface between these electrodes and the nervous system is a vital part of the 
function of the bionic device. However, in cases of long-term hearing loss the auditory 
nerve degenerates and auditory nerve processes, or neurites, retract away from the 
cochlea and the intra-cochlear electrodes. This leads to a loss of effectiveness of the 
cochlear implant. Currently the only remedy for this problem is to amplify the electrical 
signals provided to the implant, but this causes shorter battery life due to the higher 
currents and voltages and can potentially be damaging to the tissues in and surrounding 
the cochlea. This work describes attempts to develop a material which can be coated 
onto cochlear electrodes to preserve auditory nerves, potentially improving the interface 
between the cochlear implant and the auditory nerve. 
 
The material used throughout this work, polypyrrole, is a conducting polymer. Due to 
its unique proerties, polypyrrole can be used to incorporate and release charged 
molecules with different electrical stimuli. The work presented within this thesis 
describes the development of polypyrrole to release nerve growth factors, which are 
also known as neurotrophins, in order to improve auditory nerve survival and growth. 
With delivery of nerve growth factor in response to the electrical stimuli provided by 
the cochlear implant, it is hoped that better nerve survival will lead to an improved 
nerve/cochlear electrode interface, and better function of the implant. Extensive tests on 
the release of radiolabelled neurotrophins from polypyrrole substrates were performed 
under a variety of conditions in order to optimise both the material and the electrical 
stimulation used for controlled release. The focus of most work was neurotrophin-3, the 
member of the neurotrophin family of proteins that has the most widespread action on 
cell receptors.  
 
Testing of the response of auditory nerve tissue dissected from rats showed th  
neurotrophins released from polypyrrole promoted the survival and growth of nerves in
- iii - 
vitro. From these experiments, it was determined that electrical stimulation was 
effective in controlling the release of neurotrophins to improve neurite outgrowth to a 
significant degree. Based on these results in vivo xperiments were undertaken, in which 
guinea pigs were implanted with cochlear electrodes coated with polypyrrole. From 
these experiments, it was determined that electrical stimulation to promote neurotrophin 
release helped not only to prevent implantation trauma, but also to prevent deafening-
related degeneration of auditory nerves observed in untreated cochleae. 
 
Additionally, some further optimisation of the materials was completed. Another 
neurotrophin, brain derived neurotrophic factor, has been shown to work synergistically 
with neurotrophin-3, and the release of both neurotrophins from a single polypyrrole 
film was investigated. While the release of the proteins was not as well controlled, the 
effect of release on auditory nerve explants cultured in vitro was significantly greater 
than either neurotrophin alone. Studies exploring release of neurotrophin-3 from PPy 
coated on several novel substrates were performed, suggesting that biodegradable and 
nanostructured materials can be used to further tailor the release of therapeutic proteins 
from polypyrrole. An implantable power source - a biobattery - was also used to 
electrically control the release of neurotrophin-3, highlig ting the potential for a totally 
implantable system for the controlled release of therapeutic molecules using the 
polypyrrole materials developed.  
 
The insights gained in the course of this work may have implications for the controlled 
release of other therapeutic molecules frm po ypyr ole. Additionally, the information 
contained within this thesis could also have relevance beyond the scope of the cochlear 
implant/neural interface, with potential for use in other bionic devices or in nerve repair 
applications. The work described here demonstrates the potential to enhance nerve/ 
electrode interfaces using polypyrrole to electrically control the release of 
neurotrophins. 
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ABBREVIATION AND NOT ATION  
2D  two dimensional 
3D  three dimensional 
-6
g   microgram, a measure of mass. 1 g = 1 X 10 g 
-6L  microlitre, a measure of volume. 1L = 1 X 10L 
Ag|AgCl  silver|silver chloride reference electrode 
Au  gold 
BDNF   Brain-derived Neurotrophic Factor 
CAM   Cell Adhesion Molecule 
CNT   carbon nanotube 
CS  chondroitin sulfate 
CV   cyclic voltammetry or cyclic voltammogram 
CVD   chemical vapour deposition 
DAPI  40 6-diamidino-2-phenylindole 
DBS   dodecylbenzene sulfonate 
DMEM   Dulbeccos Modified Eagles Medium 
ECIS  Electric Cell-substrate Impedance Sensing 
EDTA   ethylene diamine tetra acetic acid 
EtOH  ethanol 
Fe  iron 
Fe(III).pTS  iron (III) para-toluene sulfonate 
FeCl  iron chloride 3
GP  guinea pig 
H O   hydrogen peroxide 2 2
HA   hyaluronic acid 
HEM   HEPES -buffered Eagles media 
HEPES   (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) 
I-125  iodine-125, a radioisotope of iodine 
LiCl  lithium chloride 
mCi  milli Curie, measure of radiation strength (1 mCi = 37 MBq) 
Mg   magnesium 
MgCl  magnesium chloride 
min  minute 
MPa   megapascals 
MWNT   multi-walled carbon nanotube 
NaOH   sodium hydroxide 
NT -3  Neurotrophin-3 
PBS  phosphate-buffered saline 
PEDOT   poly(3,4-ethylenedioxythiphene) 
PEG   poly(ethylene glycol) 
pI  isoelectric point 
PLGA   poly(lactic-co-glycolic acid) 
PMAS   poly(2-methoxyaniline-5-sulfonic acid) 
PPG   poly(propylene glycol) 
PPG -PEG -PPG  poly(propylene glycol)-poly(ethylene glycol)-poly(propylene  
  glycol) 
PPy  polypyrrole 
PSS  poly(4-styrenesulfonate) 
Pt  platinum 
- xx - 
pTS  para-toluene sulfonate 
PVC   polyvinylchloride 
PVDF   polyvinylidene fluoride 
QCM   Quartz crystal microbalance 
QSPR log D  Quantitative Structure-Property Relationship algorithm  
  estimation f the distribution coefficient (log D) 
2
R   R-squared value, the square of the correlation coefficient of linear  
  regression 
rpm  revolutions per minute 
SEM   scanning electron microscopy/microscope 
SGN   spiral ganglion neuron 
TrkB  receptor tyrosine kinase B 
TrkC  receptor tyrosine kinase C 
UV   ultraviolet 
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